The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may pose heightened risks for...

TUESDAY, Jan. 21, 2025 -- Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such...

TUESDAY, Jan. 21, 2025 -- Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such...

New research into widely used weight loss drugs, including Ozempic, reveals significant health risks. These drugs, initially developed for diabetes...

GLP-1RA weight-loss drugs provide health benefits but also pose risks, including pancreatitis, kidney problems, and gastrointestinal issues.

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand...

Weight-loss drugs such as Ozempic can help people to lose more than a fifth of their body weight and have been linked to a range of other health...

The impact of Ozempic and other GLP-1 receptor agonists like Wegovy, Mounjaro, and Zepbound on the alcohol and wine industry appears to be...

Times: Could 'bespoke' weight-loss drugs be the future?